More than 100 000 women older than 70 years are diagnosed with hormone receptor-positive, early-stage breast cancer each year in the USA.1 A large proportion are at low risk of disease recurrence, ...
While speaking on her podcast Tea Time with Raven & Miranda, which she co-hosts with wife Miranda Pearman-Maday, the Disney ...
Raven-Symoné recalled having her first breast reduction when she was just 15 years old. While speaking on her podcast Tea ...
Raven-Symoné recalls being pushed to alter her body in order to get a television show at the tender age of 15.
While under competitive pressure from Novartis and Eli Lilly, Pfizer can tally up a unique trial win for its Ibrance in a ...
The benefit of the PARP inhibitor in patients with germline BRCA pathogenic variants remains evident 10 years after the first ...
The median time from breast cancer diagnosis to surgery was 0.8 years for risk-reducing mastectomies and three years for risk ...
Receiving immediate surgery was associated with a reduction in local recurrence of breast cancer in elderly patients versus delaying surgery.
Interim overall survival (OS) analyses at 31% maturity in patients with ESR1 mutations, and 23% maturity among all patients, ...
Patients with ER-positive/HER2-negative metastatic breast cancer who received elacestrant experienced a significant reduction ...
Imlunestrant, an investigational next-generation selective estrogen receptor degrader (SERD), improved progression-free ...
Immediate surgery can improve outcomes among women age 70 and older who are not receiving radiotherapy, data suggest.